Quantification of human brain benzodiazepine receptors using [ 18 F]fluoroethylflumazenil: A first report in volunteers and epileptic patients

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 12, 2003, Pages 1630-1636

  Levêque, Philippe ^a   Sanabria Bohorquez, Sandra ^b   Bol, Anne ^a   De Volder, Anne ^a   Labar, Daniel ^a   Rijckevorsel, K ^c   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b MERCK RESEARCH LABORATORIES   (United States)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Benzodiazepine receptor; Epilepsy; Flumazenil; Fluoroethylflumazenil; Positron emission tomography

Indexed keywords

BENZODIAZEPINE RECEPTOR; FLUMAZENIL; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLFLUMAZENIL F 18; RADIOISOTOPE; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTERIAL BLOOD; ARTICLE; BINDING AFFINITY; BOLUS INJECTION; CASE REPORT; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; IMAGING; MALE; METABOLITE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIOACTIVITY; RECEPTOR BINDING;

EID: 0346103818     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1304-0     Document Type: Article

References (14)

1. Moerlein SM, Perlmutter JS. N-ω-[F-18]fluoroalkylated flumazenil: potential agent for mapping cerebral benzodiazepines recpetors with PET. J Nucl Med 1990; 31:902.
2. 18 F]fluoroethyl)flumazenil to central benzodiazepine receptors measured in living baboon by positron emission tomography. Eur J Pharmacol 1992; 218:109-115.
3. 18 F]fluoroethylflumazenil metabolites using high-performance liquid chromatography and tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 2001; 754:35-44.
4. 18 F]fluoroethylflumazenil in rodents. Nucl Med Biol 2001; 28:809-814.
5. 18 F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors. Eur J Nucl Med 2001; 28:1463-1470.
6. 11 C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11:735-744.
7. Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab 2001; 21:635-652.
8. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16:834-840.
9. Sibomana M, Daisne J, Bol A, Lonneux M, Gregoire V, Michel C. Head and neck multimodality volumes visualization methods. IEEE Nuclear Science Symposium and Medical Imaging Conference Record 2002.
10. Sibomana M, Coppens A, Lonneux M, Gerber B, De Volder A, Blin J, Bol A, Michel C, Byars L. Volumic image analysis application bundle for UNIX workstations. IEEE Nuclear Science Symposium and Medical Imaging Conference Record 1995:1488-1492.
11. Coppens A, Sibomana M, Bol A, Michel C. MEDIMAN: an object oriented programming approach for medical image analysis. IEEE Trans Nucl Sci 1993; 40:950-955.
12. Gunn RN, Gunn SR, Turkheimer FE, Aston JAD, Cunningham TJ. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J Cereb Blood Flow Metab 2002; 22:1425-1439.
13. 11 C]flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification. Eur J Nucl Med 2000; 27:1674-1683.
14. Van Bogaert P, Massager N, Tugendhaft P, Wikler D, Damhaut P, Levivier M, Brotchi J, Goldman S. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage 2000; 12:129-138.